𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The emerging role of the endocannabinoid system in cardiovascular disease

✍ Scribed by Pál Pacher; Sabine Steffens

Publisher
Springer-Verlag
Year
2009
Tongue
English
Weight
825 KB
Volume
31
Category
Article
ISSN
1863-2297

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Homeostatic changes of the endocannabino
Homeostatic changes of the endocannabinoid system in Parkinson's disease
✍ Valerio Pisani; Graziella Madeo; Annalisa Tassone; Giuseppe Sciamanna; Mauro Mac 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB

Endocannabinoids (eCBs) are endogenous lipids that bind principally type-1 and type-2 cannabinoid (CB 1 and CB 2 ) receptors. N-Arachidonoylethanolamine (AEA, anandamide) and 2-arachidonoylglycerol (2-AG) are the best characterized eCBs that are released from membrane phospholipid precursors through

Fatty acid amide hydrolase: an emerging
Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system
✍ Benjamin F Cravatt; Aron H Lichtman 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 179 KB

The medicinal properties of exogenous cannabinoids have been recognized for centuries and can largely be attributed to the activation in the nervous system of a single G-protein-coupled receptor, CB1. However, the beneficial properties of cannabinoids, which include relief of pain and spasticity, ar